Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

UK279276

Known as: UK-279,276 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Background and objectiveThis case study describes the pharmacokinetic and pharmacodynamic modelling undertaken during the… Expand
Is this relevant?
2006
2006
UK-279,276, or recombinant neutrophil inhibitory factor (rNIF), is a glycoprotein that binds to the human CD11b receptor (IC50… Expand
Is this relevant?
2005
2005
PurposeUK-279,276 is a recombinant glycoprotein and is a selective antagonist of CD11b, which in preclinical models of acute… Expand
  • figure 1
  • figure 2
  • figure 3
  • table II
  • figure 4
Is this relevant?
Review
2005
Review
2005
BACKGROUND Acute ischemic stroke is a complex disease. Treatment success may require combining different therapeutic approaches… Expand
Is this relevant?
2004
2004
To the Editor: Recently, the results of the Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN) were published.1 In this… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND AND PURPOSE UK-279,276 (neutrophil inhibitory factor) reduced infarct volume in a rat middle cerebral artery occlusion… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2003
2003
BACKGROUND AND PURPOSE UK-279,276, a recombinant glycoprotein, binds selectively to the CD11b/CD18 integrin on neutrophils and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND AND PURPOSE We evaluated the neuroprotective effect of UK-279,276 (also referred to as recombinant neutrophil… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2003
2003
1. UK-279,276 or recombinant neutrophil inhibitory factor (rNIF) is a glycoprotein that has been investigated as an intravenous… Expand
Is this relevant?